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Abstract:
Life expectancy in most developed countries has been rising over the last 
century. In the UK alone, there are around 12 million people over 65 
years old and centenarians have increased by 85% in the past 15 years. 
As a result of our ageing population, which is due mainly to 
improvements in medical treatments, public health, improved housing 
and lifestyle choices, there is an associated increase in prevalence of 
pathological conditions, such as metabolic disorders, type 2 diabetes 
(T2D), cardiovascular and neurodegenerative diseases, many types of 
cancer and others. Statistics suggest that nearly 54% of elderly people 
in the UK live with at least two chronic conditions, revealing the urgency 
for identifying interventions that can prevent and/or treat such disorders. 
Non-pharmacological, dietary interventions such as caloric restriction 
(CR) and methionine restriction (MR) have revealed promising outcomes 
in increasing longevity and preventing and/or reversing the development 
of ageing-associated disorders. In this review, we discuss the evidence 
and mechanisms that are involved in these processes. FGF21 and H2S 
are important molecules involved in the effects of CR and MR in the 
extension of life span. Their role is also associated with the prevention of 
metabolic and cognitive disorders, highlighting these interventions as 
promising modulators for improvement of health span.
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7 Abstract
8 Life expectancy in most developed countries has been rising over the last century. In the 
9 UK alone, there are around 12 million people over 65 years old and centenarians have 
10 increased by 85% in the past 15 years. As a result of our ageing population, which is due 
11 mainly to improvements in medical treatments, public health, improved housing and 
12 lifestyle choices, there is an associated increase in prevalence of pathological conditions, 
13 such as metabolic disorders, type 2 diabetes (T2D), cardiovascular and neurodegenerative 
14 diseases, many types of cancer and others. Statistics suggest that nearly 54% of elderly 
15 people in the UK live with at least two chronic conditions, revealing the urgency for 
16 identifying interventions that can prevent and/or treat such disorders. Non-
17 pharmacological, dietary interventions such as caloric restriction (CR) and methionine 
18 restriction (MR) have revealed promising outcomes in increasing longevity and 
19 preventing and/or reversing the development of ageing-associated disorders. In this 
20 review, we discuss the evidence and mechanisms that are involved in these processes. 
21 FGF21 and H2S are important molecules involved in the effects of CR and MR in the 
22 extension of life span. Their role is also associated with the prevention of metabolic and 
23 cognitive disorders, highlighting these interventions as promising modulators for 
24 improvement of health span.
25 Introduction
26 Life expectancy in most developed countries has been rising over the last century. 
27 Data from the Human Mortality Database suggest that children born during the 2000s 
28 will reach 100 years of age if the present life expectancy rate remains.(1) In the UK, there 
29 are around 12 million people over 65 years old and centenarians have increased by 85% 
30 in the past 15 years.(2) The population of developed countries is ageing as a result of the 
31 discovery of new drugs and treatments, improvements in public health, low fertility rates, 
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32 and changes in the lifestyle of the population.(3) However, ageing is associated with the 
33 prevalence of pathological conditions, such as neurodegenerative disease,(4,5) type 2 
34 diabetes (T2D),(6) cardiovascular diseases,(7,8,9) many types of cancer,(10) and others. 
35 Statistics show that nearly 54% of elderly people in the UK live with at least two chronic 
36 conditions, referred to as multi-morbidity,(11) hence the urgency of identifying 
37 interventions that can prevent/treat such disorders and eventually promote the health span 
38 extension. 
39 Several lifestyle modifications have been the focus of study as an approach to 
40 delay the onset of chronic diseases and the ageing process. Dietary interventions such as 
41 caloric restriction (CR) and more specifically, methionine restriction (MR), show 
42 promising outcomes in increasing longevity. This improvement is associated with the 
43 prevention of ageing-associated disorders and cognitive decline. Thus, understanding the 
44 mechanisms involved in life span regulation, as well as control of the health span, with 
45 the prevention of development and progression of ageing-related diseases, is of utmost 
46 importance if we are to live longer lives. 
47 Sulfur-containing amino acids (SAA) and methionine metabolism
48        Amino acids that contain the element sulfur in its chemical structure are called 
49 sulfur-containing amino acids (SAA). Methionine, cysteine, homocysteine, and taurine 
50 are the four amino acids included in this class, being the first two considered the main 
51 SAA because they are incorporated into proteins. They are known to play a significant 
52 role in protein synthesis, structure, and function.(12) Both methionine and cysteine are 
53 abundant in dietary protein sources, although only methionine is classified as an essential 
54 amino acid. However, cysteine can be endogenously produced by methionine and serine 
55 in the liver and other tissues.(13) The nitrogen balance in adults and the growth rate during 
56 childhood are parameters considered for the SAA nutritional requirements. In a study 
57 with rodents fed with cereals (low protein diet), the animals restored nitrogen balance and 
58 lost body weight with the diet only after methionine and threonine supplementation, 
59 suggesting that both are the most rate-limiting amino acids at maintenance of body 
60 nutrition.(14) 
61       Methionine is an essential amino acid necessary for protein synthesis in prokaryotic 
62 and eukaryotic cells; it also plays a major role as an endogenous antioxidant and is 
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63 involved in several physiological and biochemical processes.(15) The methionine 
64 metabolism is responsible for the production of essential substances in many 
65 physiological pathways. The methionine cycle is the first step of methionine metabolism 
66 and includes the biosynthesis of S‐adenosylmethionine (SAM) from methionine and ATP 
67 by the methionine adenosyltransferase (MAT) (Figure 1). SAM is a key intermediate in 
68 methionine metabolism and has many chemical roles. In mammals, the main function of 
69 SAM is to serve as a methyl donor in methyltransferase reactions.(16) In the methionine 
70 cycle, SAM donates its methyl group to an acceptor metabolite, generating S-
71 adenosylhomocysteine (SAH) catalysed by methyltransferases (MTs). This product is 
72 converted to homocysteine by reversible hydrolysis. This sequence of reactions is known 
73 as transmethylation and is present in every cell. 
74 Reviewed literature evidences from the last 20 years showed that high plasma 
75 levels of homocysteine is a risk factor for the development of neurodegenerative diseases 
76 in elderly people, and can be considered a biomarker for the Alzheimer's disease and 
77 dementia.(17) Also, hyperhomocysteine is associated with vascular disease and 
78 neurotoxicity.(18) Once formed, homocysteine can be remethylated into methionine by 
79 methionine synthase (MS) or by betaine homocysteine methyltransferase (BHMT), 
80 completing the methionine cycle. MS uses 5-methyltetrahydrofolate (vitamin B12) as a 
81 co-factor for the donation of a methyl group, and BHMT requires betaine as the methyl 
82 donor.(19) Endogenous methionine formation by MS occurs in most of cells, otherwise, its 
83 synthesis using betaine occurs mainly in the liver and kidney (20) (Figure 1). 
84 Homocysteine can also be processed to cysteine via the transsulfuration pathway 
85 (TSP). The cystathionine β-synthase (CBS) is the first enzyme in the TSP and is 
86 responsible for cystathionine synthesis from the condensation of homocysteine and 
87 serine. The second key enzyme in this process is the cystathionine γ-lyase (CGL). This 
88 enzyme is responsible for the hydrolysis of cystathionine to cysteine. Furthermore, 
89 cysteine can be involved in the synthesis of proteins, glutathione (GSH) and taurine 
90 (Figure 1). The TSP and the full conversion of methionine to cysteine is an irreversible 
91 process and only occurs in a few tissues: liver, kidney, intestine, and pancreas.(12) 
92 Cysteine is considered the rate-limiting substrate for the synthesis of the antioxidant 
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93 GSH, which can act as a storage of cysteine and be broken down to favour cysteine 
94 formation when its levels are low in the cell.(21) 
95        The TSP is also responsible for production of hydrogen sulfide (H2S) from the 
96 catabolism of cysteine and homocysteine (19) (Figure 2). H2S is a gas that was classified 
97 as toxic for many years. However, more recently, H2S has been considered as a potential 
98 therapeutic agent due to its role as a vasodilator, antioxidant molecule, anti-inflammatory, 
99 and insulin release modulator.(22) Additionally, H2S provided by the TSP has been shown 
100 to be an essential molecule for the dietary restriction benefits, such as stress resistance 
101 and longevity. (23)
102  The bioavailability of methionine in the organism regulates the rate of the 
103 methionine cycle, to maintain adequate levels of this amino acid in the tissues. The low 
104 consumption of proteins or SAA alters the activity of enzymes involved in the TSP, 
105 allowing for methionine to be preserved via protein degradation. Furthermore, the 
106 concentration of SAM and homocysteine regulates the methionine flux in its metabolic 
107 pathways.(21)
108 Dietary restriction
109            Dietary interventions have been used for decades as an approach to delay ageing 
110 and the development of diseases related to cell senescence. One of the most studied forms 
111 of delaying the onset of age-related diseases is by dietary restriction (DR), which includes 
112 different nutritional interventions that can bring health benefits in a variety of 
113 species.(24,25) Studies have shown that the extension of lifespan is associated with DR in 
114 many organisms, including yeast, C. elegans, D. melanogaster, and rodents. In mammals, 
115 different dietary regimens have been associated with health benefits, including 
116 intermittent fasting, a decrease in protein intake, or reduction in daily food consumption. 
117 These interventions share some similar beneficial features, such as reduced adiposity, 
118 improved insulin sensitivity, and glucose homeostasis. However, it is important to note 
119 that differences exist between these different approaches and each one has its singularity. 
120 In rodents, longevity is mainly attributed to a delay in ageing-related processes, 
121 associated with lower incidence of the development of ageing-related diseases and 
122 neurodegeneration.(26) A reduction in the activity of nutrient-sensing signalling is 
123 possibly one of the main pathways by which DR can increase lifespan.(27,28,29) 
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124  One of the most investigated DR interventions is the caloric restriction (CR), 
125 (30,31,32) which is defined as a reduction of 20 - 40% of daily food intake with meal 
126 frequency being maintained, showing improvements in life and health span.(33) For many 
127 years, studies with rodents and primates have been providing evidence that the reduction 
128 of daily caloric intake up to 40% without malnutrition improves insulin resistance and 
129 prevents the development of several metabolic disorders associated with ageing, as type 2 
130 diabetes (T2D), hypertension, obesity, chronic inflammation and cancer.(34,35,36,37,38) CR 
131 diet is also associated with an overall decrease in mortality-related processes in 
132 primates.(39) Furthermore, moderate CR with a decrease of only 10% of calorie intake per 
133 day was associated with protection against diabetes and decrease in intrahepatic lipid 
134 content in a rodent models of obesity. (40) 
135            Clinical trials have been implemented during the years to assess the effects of CR 
136 on human health. Some of these studies revealed that CR in adult men and women 
137 improves glucose and insulin tolerance, as well as reduces the risk of T2D and 
138 cardiovascular diseases.(41) However, the calorie intake and the levels of body fat mass 
139 that are associated with the health benefits and any possibility of an increase in the life 
140 span in humans is still to be determined. Furthermore, it is important to point out that 
141 excessive CR may be accompanied by malnutrition and brings harmful effects to the 
142 individuals' health.(42) Studies performed in obese children who were on a low-
143 carbohydrate or a low-fat diet for 2 months, suggested improvements in their body weight 
144 and lipid profiles. This effect was associated with low triglyceride serum levels, revealing 
145 that DR can improve metabolic parameters in obesity.(43) Additionally, a randomized, 
146 controlled clinical study was performed that assessed the effects of CR in non-obese 
147 adults, and revealed a significant weight loss accompanied with a decrease in systemic 
148 oxidative stress and ageing biomarkers, even 2 years after the dietary intervention.(44) 
149            For decades, the effects of CR in the ageing brain and the development of 
150 neurodegenerative diseases have been a topic of intense study. Longer-term clinical trials 
151 with CR (4 and 5 years) suggest that a decrease in caloric intake over several years can 
152 decrease neuronal damage and delay the onset of symptoms related to Alzheimer's 
153 disease (AD) and Parkinson's disease (PD) in elderly individuals.(45,46) In agreement, 
154 studies examining neurodegeneration-associated behaviours and dietary interventions, 
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155 demonstrated that CR improved locomotor activity in aged rodents compared with mice 
156 fed an ad libitum diet.(47) In the same approach, CR rats did not exhibit a decline in 
157 locomotor activity associated with the ageing process, as reported in animals with free 
158 access to food.(48) In addition, mice were submitted to a long-term reduction in calorie 
159 intake (during their entire life) preventing the animals against a decline in learning due to 
160 ageing, which raises the possibility that it may also protect rodents against 
161 neurodegeneration associated with AD mutations. Indeed, a decrease in dopaminergic 
162 neuron death was observed in animal models of PD following a 3-months CR 
163 regimen.(49,50,51) 
164 Methionine restriction
165  The primary way of modulating the rate of the TSP is by altering the dietary 
166 consumption of methionine. Dietary methionine restriction (MR) is considered a dietary 
167 intervention that mimics DR, without CR. Dietary MR can alter enzymatic activity in the 
168 methionine cycle and consequently, the synthesis of its metabolites. This nutritional 
169 intervention is widely associated with the benefits observed in DR but without 
170 malnutrition; reducing adiposity but at the same time increasing both, food intake and 
171 energy expenditure.(52)
172  One of the earliest pieces of evidence that MR could increase longevity in 
173 rodents was demonstrated by Orentreich and colleagues (1993). In this study, a reduction 
174 of the SAA methionine from 0.86% to 0.17% was able to extend the life span in rodents 
175 around 30%, despite the higher food intake promoted by the diet.(53) In another study, 
176 control pair-fed animals, consuming the same amount of food as  rats on MR diet, did not 
177 exhibit an extension of life span, promoting the idea that methionine itself is the key 
178 player behind lifespan extension and not necessarily the alteration in total calories 
179 consumed.  Moreover, blood levels of GSH, a well-known antioxidant molecule, were 
180 maintained during ageing in animals on MR diet, and different rodents strains submitted 
181 to this dietary intervention revealed a slowing in the ageing process, suggesting that MR 
182 may modify the rate of ageing(54) without alterations in reactive oxygen species. 
183 Furthermore, studies with C.elegans and rodents have shown that the deletion of 
184 antioxidant enzymes, e.g. superoxide dismutase (SOD) and gluthathione peroxidase 1 
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185 (GPX1), did not alter animal lifespan and was not crucial for the ageing process,(55,56) 
186 confirming a separate role for MR in longevity. 
187  The effects of dietary MR in mice were reported by Miller and colleagues,(57) who 
188 presented evidence that MR diet is capable of increasing longevity alongside lower 
189 hepatic oxidative stress. These mice exhibited low serum levels of insulin, insulin-like 
190 growth factor 1 (IGF-1), glucose, and thyroid hormones after a long-life MR diet intake 
191 (from 6 weeks of age until natural death).(57) The modulation of rodents’ metabolism by 
192 the decrease in methionine intake was supported by the observation that rats fed MR diet 
193 for 80 weeks had higher insulin sensitivity and lower visceral fat content than animals fed 
194 control chow diet.(58) In vitro studies revealed that the decrease in adiposity observed in 
195 MR-fed rodents was due to a disruption of lipogenesis and lipolysis cycle, with a high 
196 rate of both, lipid catabolism and lipid synthesis.(59)
197 A clinical trial including 26 adults (6 male and 20 female) with metabolic 
198 syndrome reported that individuals provided with the MR diet for 16 weeks, or a control 
199 diet, decreased body weight and fasting glycemia, irrespective of the diet. Interestingly 
200 however, a specific effect only observed in the MR group of volunteers was a decrease in 
201 the intrahepatic lipid content and increased fatty acid oxidation. However, this study 
202 presented elevated levels of non-compliance in human participants due to poor 
203 palatability of the diet. In order to achieve better responses in humans during clinical 
204 trials, it is necessary to develop more palatable tasting food in which methionine is 
205 selectively decreased. (60) 
206 To understand the physiological mechanisms triggered by dietary MR, a 
207 hyperinsulinemic-euglycemic clamp was performed in mice after MR treatment. The 
208 mice exhibited a decrease in hepatic gluconeogenesis, followed by higher insulin 
209 sensitivity in the liver and high serum levels of the fibroblast growth factor 1 (FGF21), 
210 providing evidence of a direct effect of methionine in liver metabolism and FGF21 
211 availability.(61) Increased levels of FGF21 are associated with positive metabolic 
212 outcomes, as it has been shown to reduce insulin resistance and hepatic lipids levels in 
213 obese and diabetic mice.(62,63) FGF21 is a growth factor released mainly in response to 
214 fasting by the liver, being shown to regulate important metabolic pathways.(64) In 
215 humans, FGF21 is highly expressed after 7 days of fasting and regulates the energy 
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216 balance during this period by adapting metabolic signalling to the reduction of 
217 nutrients.(65)
218 Furthermore, MR was able to decrease lipogenic genes in the liver of aged mice 
219 and increase insulin sensitivity in white adipose tissue (WAT) and skeletal muscle. 
220 Alongside these findings, aged mice had higher serum and hepatic levels of FGF21, 
221 associated with lower circulated leptin levels after 8 weeks of MR. Furthermore, 
222 increased FGF21 levels were seen in a short-term 48-hour MR regimen, together with 
223 improved whole-body glucose homeostasis. These improvements occurred prior to 
224 alterations in animals' body weight/adiposity, adding evidence that MR itself drives the 
225 improvements in whole body metabolism. The authors suggested that the MR effects 
226 observed were most likely driven by FGF21. (66) Similar increase in FGF21 levels was 
227 observed after only 12 hours of MR diet switch in the serum and liver of mice.(61) High 
228 FGF21 levels were maintained after 1, 2 and 4 weeks of MR intake.(61) Recently, a 
229 clinical trial with overweight and obese women on a low methionine and cysteine diet for 
230 one week revealed a significant increase in FGF21 plasma levels. However, the role of 
231 each specific amino acid restriction in the modulation of FGF21 content could not be 
232 separated, which is a limitation of this study. (67)
233  Previous work in aged male rats had shown that MR feeding improved oral 
234 glucose tolerance maintenance.(58) Our own work compared young (2 month) vs aged 
235 mice (12 month) and presented the idea that MR could improve glucose homeostasis after 
236 longer (8 weeks) as well as short-term (2 days) restriction, supporting the hypothesis that 
237 MR can reverse the age-induced deterioration in glucose and lipid metabolism and 
238 handling.(66) These pieces of evidence can be associated with findings that MR increases 
239 energy expenditure in young and aged mice together with elevated heat production, 
240 which is mainly due to increased brown adipose tissue (BAT) activation and higher 
241 uncoupling protein 1 (UCP1) expression in this tissue. (68) Knowing that UCP1 expression 
242 is also high in WAT during MR, Ucp1-/- mice were subjected to MR. The findings 
243 revealed that the uncoupling respiration in cells is essential for the effects of MR in 
244 increasing energy expenditure, but not for improving insulin sensitivity in this tissue. The 
245 remodelling of metabolic function in MR animals is integrated with a lower metabolic 
246 efficiency as observed with the behaviour of hyperphagia, suggesting the involvement of 
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247 a nutrient-sensing mechanism that could compensate for the reduction in methionine by 
248 alterations in the body's energy homeostasis. (69) Moreover, the increase in energy 
249 expenditure, energy intake, BAT and WAT thermogenesis is abolished in Fgf21-/- mice 
250 fed MR diet, which also showed lower insulin sensitivity when compared wild type mice 
251 on MR. These data demonstrated that FGF21 is an essential mediator of the MR effects 
252 observed in rodents. (70) Additionally, a more recent study, where rats were introduced to 
253 MR diet postweaning or at mature age, resulted in different hyperphagia outcomes. In 
254 young animals, the hyperphagic effect of MR resulted in an increase in energy intake that 
255 overcomes the higher energy expenditure; an effect not observed in ageing rats, 
256 indicating that MR could have different outcomes depending on age. (71)  
257 Methionine restriction and obesity
258  Obesity and diabetes are the major metabolic disorders of public health relevance 
259 that have an urgent need for effective interventions. MR promotes loss of body weight 
260 and adiposity, increases glucose tolerance, insulin sensitivity, and overall fatty acid 
261 oxidation, which makes it a promising lifestyle intervention to tackle these disorders. 
262 (57,60,61,66) To investigate if MR could ameliorate obesity, ob/ob mice were placed on the 
263 diet for 12 weeks; this improved their hepatic lipid profile, with no changes in insulin 
264 sensitivity, body weight, and/or adiposity. (72) However, this animal model has an 
265 impaired β-adrenergic input, which may correlate with the lack of adipose tissue response 
266 to MR. In addition, ob/ob mice on MR failed to increase adiponectin serum levels, 
267 suggesting a possible role for this hormone in insulin sensitizing effects mediated by 
268 MR.(72) Interestingly, the metabolic effects of MR had been investigated previously in the 
269 same ob/ob mouse model, resulting in an improvement of hepatic steatosis that developed 
270 after 14 weeks of treatment. This effect was accompanied by a reduction in hepatic 
271 triglycerides levels, a high rate of fatty acid oxidation, and downregulation of 
272 inflammatory markers. Insulin levels were also decreased in this study together with 
273 increased adiponectin levels.(73) The mechanism by which MR regulates liver metabolism 
274 could be related to modulation of micro RNA (miRNA) expression. MR in young and 
275 diet-induced obese mice promotes repression and upregulation of several miRNAs that 
276 control synthesis and transport of cholesterol, fatty acids, and insulin,  suggesting that 
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277 that the hepatic benefits of MR in rodents occurs through multiple mechanisms to prevent 
278 the accumulation of lipids. (74)
279  MR diet also appears to improve cardiovascular function in obesity. In diet-
280 induced obese mice, submitted to MR, the dietary intervention led to improved systolic 
281 function in middle age (28 weeks old), and was accompanied by a decrease in cardiac 
282 inflammation and oxidative stress. (75) This overall improvement in cardiac function was 
283 associated with increased levels of H2S in the heart promoted by the diet (Han, 2020). 
284 MR seems to improve cardiovascular function despite the elevated heart: body weight 
285 ratio and hyperhomocysteinemia, which are features associated with a high risk of 
286 cardiovascular diseases. (75) Ables and colleagues (2015) reported that mice with high 
287 plasma levels of homocysteine did not have their cardiac function altered following a MR 
288 intake, due to the upregulation of cardioprotective hormones, FGF21 and adiponectin by 
289 the diet.(76) Indeed, there is evidence to suggest that high methionine intake could be 
290 associated with aortic plaque formation. APOE-/- mice fed methionine supplementation, 
291 exhibited high homocysteine levels and increased total aortic lesion area, indicating that 
292 methionine levels, and not homocysteine itself, are related to cardiovascular diseases.(77) 
293 A recently published clinical trial in North-American (11,567 people) assessed the 
294 association between the cardiometabolic disease risk and the content of SAA intake in 
295 their diet. The study reported that a high intake of SAA, methionine, and cysteine was 
296 closely associated with a cardiovascular disease risk score, high serum cholesterol, 
297 glucose, uric acid, insulin, and glycated haemoglobin levels. (78) These findings suggest 
298 that low SAA intake, including MR diet, could be a potential intervention to reduce the 
299 risk of cardiovascular diseases. 
300 Methionine restriction and diabetes
301  The development of insulin resistance and T2D have been associated with 
302 increased serum levels of methionine and cysteine in many clinical trials, usually before 
303 the onset of clinically diagnosed T2D. (79,80,81). A large cross-sectional study with more 
304 than 16,000 individuals showed that the plasma concentration of cysteine was correlated 
305 with the body mass index (BMI) and these levels were specifically related to body mass 
306 and not lean mass. (80,81) Moreover, metabolite profile studies indicated that alterations in 
307 methionine concentration in the plasma may be indicative of insulin resistance and the 
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308 risk of T2D. Non-diabetic obese adults had increased circulating levels of methionine if 
309 compared with non-obese patients.(79) Also, male patients with T2D show high levels of 
310 homocysteine in the blood with lower methionine transmethylation and homocysteine 
311 clearance, suggesting an impaired methionine metabolism in this condition. (82) Taken 
312 together, these studies propose that changes in metabolism and glucose homeostasis alter 
313 SAA metabolism, ultimately resulting in alterations in methionine and cysteine 
314 circulating levels. 
315  MR diet has been shown to ameliorate glucose tolerance and insulin sensitivity in 
316 several experimental models, preventing the development of T2D. Insulin resistance 
317 prone C57Bl/6J mice fed a high-fat methionine restricted diet were found to be more 
318 glucose tolerant, with increased insulin sensitivity and decreased intra hepatic lipids, in 
319 comparison to high-fat control diet animals. This was associated with high levels of 
320 FGF21 and adiponectin, and low circulating levels of leptin and IGF-1. (83) Dietary MR 
321 was shown to increases overall insulin sensitivity and tissue-specific insulin sensitivity 
322 (liver, skeletal muscle, heart and adipose tissue), by an enhanced insulin-dependent 
323 protein kinase B (PKB/Akt) phosphorylation.(61) More recently, New Zealand obese 
324 (NZO) mice, a model for polygenic obesity and T2D, were fed a high-fat diet on MR for 
325 9 weeks. MR diet prevented the onset of hyperglycemia in NZO mice and increased 
326 FGF21 levels, as well as adiponectin and thermogenic genes in WAT. The same study 
327 compared both, vegan and vegetarian diet with an omnivore diet in adults, with evidence 
328 that a low protein diet increased FGF21 levels in humans. These hormones were also 
329 increased after omnivore individuals switched their diet to a vegetarian diet for 4 days, 
330 suggesting a short-term metabolic beneficial effect of reducing protein intake.(84) 
331  The improvement in glucose homeostasis and insulin sensitivity due to MR may 
332 be related to improved insulin signalling in the tissues and insulin secretion by the 
333 pancreas. In vitro studies demonstrated that the limitation of methionine concentration in 
334 HepG2 cell media promotes higher PKB/Akt phosphorylation, with a similar pattern 
335 occurring in skeletal muscle and WAT of mice fed an MR diet.(61) Similar observations 
336 were made in the kidneys of mice on MR for 8 weeks. Aged mice on MR had enhanced 
337 insulin-stimulated phosphorylation of PKB/Akt and ribosomal protein S6 (S6). MR diet 
338 also induced upregulation of UCP1, Srt1, FGF21, klotho, and B-klotho gene expression, 
Page 12 of 37
Cambridge University Press
Proceedings of the Nutrition Society
For Peer Review
12
339 suggesting resistance or reversal to the ageing process in this tissue.(85) Corroborating 
340 these findings, the supplementation of methionine in a low-protein diet eliminated the 
341 beneficial effects observed in diabetic kidneys by the reduction of protein intake in 
342 diabetic rats. The specific effects of low methionine provided by the low-protein diet 
343 were regarding anti-oxidative stress, anti-inflammation, and anti-fibrosis features in the 
344 diabetic kidney, possibly via the mechanistic target of rapamycin complex 1 (mTORC1) 
345 in this tissue.(86) Investigating further the effects of MR on the insulin signalling pathway, 
346 a mouse model of hepatic protein tyrosine phosphatase 1B (PTP1B) knockout was fed 
347 with MR for 8 weeks. The results suggested no additional synergetic effect of PTP1B 
348 knockout and MR in insulin sensitivity and lipid metabolism, suggesting that the hepatic 
349 MR effects are either not mediated by PTP1B pathway or that there is a ceiling level to 
350 which either/both interventions can improve glucose homeostasis.(66)
351  There is currently no evidence that MR can directly modulate insulin secretion by 
352 the pancreas. However, H2S levels may be an insulin-release modulator in pancreatic 
353 beta-cells. It was demonstrated that H2S inhibits insulin secretion stimulated by glucose 
354 and decreases the insulin-stimulated glucose uptake by adipocytes.(87) Nonetheless, the 
355 administration of a CGL inhibitor can enhance glucose uptake in adipocytes, which 
356 suggests that H2S might be a novel insulin resistance regulator. Also, in diabetic rats, the 
357 CGL pathway is enhanced, confirming the H2S role in insulin sensitivity in adipose 
358 tissue.(87) However, the H2S effect may differ depending on tissue type, as in the liver 
359 H2S has been reported to stimulate gluconeogenesis and glycogenolysis and inhibit 
360 glucose catabolism and glycogen storage.(88) In addition, high-fat diet and the 
361 development of diabetes stimulate a reduction of CGL and H2S production in the rat 
362 livers.(89,90) Thus, modulation of the TSP and H2S production by MR might indirectly 
363 intervene with insulin secretion and glucose uptake by the tissues. 
364  Recent evidence suggests that the effects of MR in metabolic health and insulin 
365 sensitivity may also differ between sexes. A short-term MR dietary regimen (1 week) was 
366 introduced in male and female diet-induced obese mice, showing an improvement in 
367 glucose tolerance in both sexes, as expected. However, MR was able to increase energy 
368 expenditure and induce the FGF21-UCP1 axis only in males.(91) These findings were 
369 corroborated by evidence that only male mice had their lean mass preserved after MR, 
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370 while the female mice had a preference to maintain their fat mass, suggesting a sexually 
371 dimorphic effect of MR in young mice.(92) However, the underlying mechanisms in MR 
372 responsiveness related to glucose homeostasis and insulin sensitivity in males vs. females 
373 still need to be investigated. 
374   An alternative, pharmacological approach has also been employed to simulate 
375 dietary MR. In vivo studies with an oral recombinant methioninase (rMETase), which 
376 catabolized methionine to α-ketobutyrate and ammonia, has been shown to prevent diet-
377 induced obesity, increase glucose tolerance and decrease fat mass in mice fed a high-fat 
378 diet.(93) Hepatic lipids were also reduced in male mice after rMETase treatment, 
379 suggesting a role for this intervention in preventing fatty liver and obesity in rodents.(93) 
380 However, no clear evidence has been offered regarding the duration of effects caused by 
381 this intervention, and what side effects there may be, bringing attention to the need for 
382 more studies in this area. It is nevertheless confirmation that decreasing the levels of 
383 methionine, either through dietary or pharmacological interventions, may be a promising 
384 and achievable way of preventing the onset of diabetes and obesity, and improving 
385 overall metabolic health, thus health span. 
386 Methionine restriction and cognitive function
387            The influence of different dietary intervention and prevention, to improve memory 
388 or delay the onset of neurodegenerative diseases, has been a topic of great 
389 interest.  During ageing, several functional and structural alterations occur in the brain 
390 that impair neuroplasticity and memory.(94,95,96) Initial studies demonstrated that CR can 
391 enhance spatial memory in rodents, with age-related motor impairment and learning 
392 being prevented following CR for 4 months.(97,49) CR has also been associated with 
393 improving synaptic activity and stimulation of neuroprotective signalling in the 
394 brain.(98,99,100) In a state of CR, the brain can produce more brain-derived neurotrophic 
395 factor (BDNF), offering neuroprotection.(99) Experimental evidence revealed previously 
396 that CR induced neurogenesis in the dentate gyrus of the hippocampus is associated with 
397 higher BDNF expression.(101) Cognitive impairments exacerbated by obesity were 
398 attenuated by CR due to higher levels of N-methyl-d-aspartate (NMDA) receptor 
399 subunits, essential for long-term potentiation (LTP) and synaptic plasticity in the 
400 hippocampus after 10 weeks.(102) However, some studies have demonstrated that CR 
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401 could act in increasing neuronal stem cells via NMDA-independent mechanisms, for 
402 example via BDNF. Altogether, improvement in the levels of NMDA receptor and 
403 synaptophysin levels in the CA3 region of the hippocampus were observed due to CR and 
404 associated with better performance in a spatial memory task.(103) 
405            Long-term CR can also improve working spatial memory in mice.(104) However, 
406 some studies associated short-term CR, at later stages of life, with modulation of 
407 biochemical markers in the brain related to cognitive decline. The neural cell adhesion 
408 molecule (NCAM) and the astrocytic marker glial fibrillary acidic protein (GFAP) were 
409 significantly elevated in 24 months-old mice after CR.(105) Late-onset short term CR 
410 regimen in rodents was also shown to prevent age-related neurodegeneration in the 
411 hippocampus and cortex of rats by decreasing oxidative stress in these regions.(106) In 
412 addition, only 7 weeks of CR in old mice (17 months old) reversed changes observed in 
413 GSH redox state in the cortex, hippocampus, striatum, and cerebellum, preventing loss of 
414 function in these areas.(107) These studies suggest that the introduction of CR in older 
415 animals may benefit brain health, preventing the tissue from ageing-related damages. 
416            Preservation of neuronal function within the ageing process is correlated with an 
417 increase in life span. The effect of CR in the maintenance of brain integrity seems to be 
418 associated with an early shift from glucose to ketone bodies' metabolism in ageing 
419 mice.(108) These findings were recently confirmed by another study revealing that CR 
420 induced high levels of neurotransmitters and neuronal integrity markers in a postprandial 
421 response.(109) Moreover, a low glycolysis activation pathway was observed following CR; 
422 these effects were not noticed in ad libitum mice. This indicates that an essential role for 
423 neuroprotection in ageing may be related to early changes in brain metabolism and 
424 glucose utilization.(109)  
425            The beneficial effects of CR in the brain have been being investigated in primates 
426 and human studies. Analysis with primates exposed to a chronic, moderate CR revealed 
427 an overall reduction in the development of ageing-associated diseases and significant 
428 preservation of the white matter in different brain regions. However, the authors observed 
429 a faster loss of grey matter without affecting cognitive performances.(110) The impact of 
430 40% CR was also evaluated in small primates (Microcebus murinus) for 19 days, 
431 demonstrating reduced learning performance. No differences in locomotor capability 
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432 were detected in the Rotarod tests.(111) In humans, a clinical trial with healthy elderly 
433 individuals reported a significant improvement in memory performance after 3 months of 
434 CR regime, compared to increased unsaturated fatty acids intake group and ad libitum 
435 controls.(112) The results were correlated with improved insulin sensitivity and reduced 
436 inflammatory markers, supporting corresponding animal studies, and the concept of 
437 conserved brain integrity.(112)    
438 The effects of MR on cognitive performance have also been investigated in recent 
439 years. Evidence suggests that obesity is not only a risk factor for the development of T2D 
440 and cardiovascular diseases, but also has been correlated with the prevalence of AD and 
441 cognitive decline.(113) High-fat diet induced obese mice exhibit impaired learning and 
442 memory, accompanied by a reduction in H2S production in the hippocampus, cortex, and 
443 plasma.(114) Higher hippocampal inflammation was also observed. However, obese 
444 animals fed high-fat and low methionine diet for the same period, improved in all 
445 behavioural tasks, alongside decr ased brain inflammation and normalization of H2S 
446 levels.(114) Dietary alterations might alter the methionine cycle, producing chronically 
447 elevated levels of homocysteine. The increased plasma concentration of homocysteine 
448 has been linked with cognitive decline, dementia, and AD,(115) being shown to induce 
449 alterations in the hippocampal plasticity and a slow-onset reduction of synaptic 
450 transmission, what confirms its possible role in the pathology of neurodegenerative 
451 diseases.(116)  
452 Recent work using C57BL/6J mice fed a high-fat diet for 4 weeks, followed by  
453 MR diet for 8 weeks, reported that MR protected the animals against overall 
454 inflammation and the brain dysfunction by potentially altering the circadian homeostasis 
455 of gut microbiota and the brain.(117) Additionally, behavioural tests performed in older 
456 mice (12 and 15-month-old) fed MR for 3 months revealed improved performance in 
457 spatial memory tasks, associated with less neuronal damage and synapse damage in the 
458 hippocampus. FGF21 levels were significantly elevated after MR; furthermore, FGF21 
459 knockdown severely blunted the MR’s effects on the ageing brain.(118) These studies 
460 suggest that MR may offer promising therapeutic intervention or even prevention of 
461 cognitive decline during ageing and in associated disorders, such as AD. 
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462 In support of this idea, a dietary protein restriction (PR) that includes reduced 
463 intake of methionine, isoleucine, leucine, phenylalanine, threonine, tryptophan, valine 
464 and arginine, improved behavioural performance in an AD mouse model. The authors 
465 found a decrease in phosphorylated tau protein in the hippocampus of 9-month-old 
466 3XTgAD mice, suggesting that PR may partially protect the brain against age-related 
467 pathologies.(119) Additionally, Tg2576 mice placed on a methionine supplementation in 
468 the diet, presented higher levels of homocysteine, which was associated with increased 
469 Aβ deposition and behavioural impairments.(120) Moreover, chronic treatment with a 
470 methionine-enriched diet promoted increased levels of phosphorylated tau and Aβ 
471 plaques, as well as higher inflammation and oxidative stress in the hippocampus of 
472 healthy mice. Memory impairments were also observed following methionine 
473 supplementation, giving rise to a neurotoxic effect of high circulating levels of 
474 methionine, however homocysteine levels were not evaluated in this study.(121) 
475 Interestingly, nutritional deficits in B vitamins might lead to 
476 hyperhomocysteinemia and the development of AD pathology. High levels of 
477 homocysteine was previously demonstrated to have a bi-directional effect on LTP in 
478 hippocampal slices of rats exposed acutely to this amino acid, showing an impairment in 
479 neuronal communication what might contribute to cognitive decline.(122) Moreover, rats 
480 exposed to long-term homocysteine daily injections (14 weeks)  showed alterations in 
481 synaptic activity and LTP in the hippocampus, together with changes in spatial 
482 learning.(123)  Furthermore, vitamin B12 deficiency is associated with poor cognition and 
483 the onset of AD(124) and was shown to stimulate PS1 and β-site APP cleaving enzyme 
484 (BACE) expression, causing more Aβ plaques deposition.(125) Vitamin B12 is associated 
485 with the methionine cycle, as mentioned previously, as well as folate and vitamin B6. 
486 Folate concentration is also a factor that could be associated with neurodegenerative 
487 diseases and neurodevelopmental disorders. Mild-cognitive impairment observed in T2D 
488 patients was correlated with low folate and SAM circulating levels.(126) Also, low levels 
489 of folate and vitamin B12 in has been widely correlated with women who gave birth to 
490 children with spina bifida.(127) These findings support the idea that modulation of the 
491 methionine cycle and its components may serve as an important tool to prevent neuronal 
492 damage and subsequent neurodegenerative diseases.
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493 Dietary restriction and Alzheimer's disease
494            Dietary interventions such as CR not only seems to improve cognition and prevent 
495 memory loss during the ageing process, but have also been associated with delayed 
496 progression of neurodegeneration.(128,129,130,131,132) Due to the rising global number of 
497 elderly people, AD is one of the most prevalent diseases of our time, thus far without 
498 effective treatment. AD is considered a multi-factorial syndrome, and its causes are still 
499 widely debated. Two types of AD are commonly recognized: sporadic and inherited 
500 (familial) AD.(133) The sporadic type is the most common form, accounting for > 90% of 
501 the cases, and usually leads to the late onset of the disease. Environmental and lifestyle 
502 factors contribute to the development of sporadic AD, including diabetes, hypertension, 
503 cardiovascular diseases, hypercholesterolemia, hyperhomocysteinemia, smoking, and 
504 others. A small number of cases (less than 1%), are causally directly inherited 
505 AD.(134,135,136) Usually, this form occurs earlier in life (from around 45 years), and results 
506 from mutations in genes for amyloid precursor protein (APP), presenilin 1 (PS1) or 
507 presenilin 2 (PS2), often also categorised by a more aggressive disease progression. The 
508 early symptoms of AD include memory impairments, mood and sleep disturbances, and 
509 anxiety. With the progression of the disease, deterioration of cognitive functions can be 
510 clinically diagnosed,(137,138) yet ultimately requires post-mortem confirmation.
511            End stage AD is characterised by two main pathological marks that include the 
512 extracellular deposition of amyloid-β peptide (Aβ) plaques, and the formation of 
513 neurofibrillary tangles containing hyperphosphorylated tau protein.(139) Importantly, 
514 recent evidence indicates that soluble, non-fibrillar forms of Aβ and Tau play a more 
515 significant causal role compared to the final, aggregated species.(140,141) An early study 
516 investigating the effects of dietary modifications to ameliorate neurodegeneration 
517 associated with AD-linked mutation was published in 1999. The investigators found that 
518 DR for 3 months in PS1 knock in mice (which exhibit spatial memory deficits at 6 
519 months of age)(142) resulted in less damage to hippocampal CA1 and CA3 neurons when 
520 compared with ad libitum fed animals.(143) In the following years, studies using AD 
521 transgenic mice revealed that a short-term CR (4 weeks) can reduce Aβ accumulation;(130) 
522 a similar pattern was detected in APP/PS1 mutated mice in long-term CR (18 weeks) 
523 resulting in a decrease in neuritic plaque deposition.(144) Female Tg2576 mice (carrying a 
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524 double APP mutation,(145) also presented a decrease in Aβ plaque formation after 9 
525 months of a CR diet. The authors reported that CR may promote anti-amyloidogenic α-
526 secretase activity and decrease components of the pro-amyloidogenic γ-secretase 
527 complex.(131,146) Furthermore, CR improved age-related behavioural deficits in a triple-
528 transgenic rodent model of AD (3xTgAD, overexpressing mutated PS1, APP and 
529 Tau).(147) At 17 months of age, 3XTgAD mice on CR diet for 14 months performed better 
530 in the water maze task and displayed higher exploratory behaviour than animals on the ad 
531 libitum diet. Hippocampal levels of Aβ40, Aβ42, and phospho-tau were also decreased 
532 after CR.(148) Elderly humans free of dementia were followed for 4 years. Between the 
533 individuals who carried the apolipoprotein E (ApoE) e4 allele, those who their daily 
534 calorie intake was elevated showed higher risk of AD,(46) supporting the idea that the 
535 reduction in caloric intake could improve AD-like symptoms. 
536            Further studies have been conducted to understand the mechanism(s) by which CR 
537 may improve memory and cognition in several animal models. C57/BL6J mice, receiving 
538 CR diet for 10 months, presented with enhanced learning and memory capacity in the 
539 water maze, associated with a decrease in inflammatory and insulin signalling markers 
540 and activation of autophagy.(149) Furthermore, modulation of apoptosis seems to be 
541 regulated by CR. Ma and colleagues(150)  observed a reduction in apoptosis markers in the 
542 hippocampus of C57/BL6J mice on 10 months of CR, which was associated with 
543 improved memory in behavioural tests.(150) Finally, the same authors reported 
544 improvements in hippocampus-dependent spatial learning associated with higher 
545 adenosine monophosphate-activated protein kinase (AMPK) and glucose transporter 4 
546 (GLUT4) levels in the hippocampus, suggesting a possible role of AMPK in this 
547 process.(151) Another study demonstrated a correlation between neuroprotective effects of 
548 CR in PDAPP-J20 mice for 6 weeks with modulation of glial cells and the autophagy 
549 processes.(152) Moreover, ApoE-deficient mice on CR exhibited increased post-synaptic 
550 (PSD95) -positive neurons and elevated levels of FGF21 in both, plasma and brain, 
551 associated with improved performance in the water maze. This evidence suggested that 
552 the neuroprotection of CR may also be dependent on FGF21 signalling,(153) similar to 
553 evidence presented above for metabolic disorders. 
554 CONCLUSION
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555            Dietary disease prevention and interventions that extend the life span and 
556 ameliorate the impact of ageing have received attention in recent years as a method of 
557 extending the period free of disease; i.e. the health span. CR (without causing 
558 malnutrition and deficiencies) is one of the most studied forms of prevention and/or 
559 reversal of age-related disorders. The reduction in caloric intake can improve brain health 
560 and may be a good candidate for reducing the risk of dementia, especially in midlife.(154) 
561 However, caution is warranted here, as the controversies surrounding underweight and 
562 extreme weight changes and dementia remain unresolved.(155) 
563 Ultimately, current evidence suggests that the total amount of calories is not the 
564 key parameter responsible for health benefits, but rather the reduction of specific 
565 macronutrients in the diet.(156) Even tough CR can decrease body weight/adiposity and 
566 increase insulin sensitivity, the underlying mechanism(s) are still not well understood. In 
567 addition, long-term CR in humans may not be achievable and cause a range of 
568 deficiencies along the way. Ther fore, dietary restriction related to specific nutrients, 
569 without CR, offers an attractive alternative, achievable in humans. 
570 One such dietary intervention is MR, which can mimic the positive health span 
571 effects of CR without the associated reduction in food intake. Decreasing the amount of 
572 methionine in the diet has been suggested as a promising strategy to extend longevity, 
573 prevent and/or reverse obesity and metabolic disorders, with many of the effects being 
574 driven by its ability to induce FGF21 secretion and production. However, palatability of 
575 the MR manipulated diets should be improved to gain more compliance from humans. 
576 Vegan diets and foods naturally low in methionine such as green leafy vegetables, nuts, 
577 fruits and beans, could possibly recapitulate the positive effects of MR on metabolism; 
578 however, these may not be appropriate for children, pregnant women or elderly. Positive 
579 outcomes of MR were also reported for cognitive processes, thus opening an opportunity 
580 of developing MR mimetics for the prevention of AD and other neurodegenerative 
581 diseases. To achieve this, further studies are necessary to identify cellular mechanisms, 
582 pathways and targets underpinning the neuropathology of the disease and the role of 
583 methionine therein.
584
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585 Figure 1: Methionine cycle and transsulfuration pathway (TSP). Methionine is 
586 converted to S ‐ adenosylmethionine (SAM) by the methionine adenosyltransferase 
587 (MAT). Methyltransferases (MTs) produce S-adenosylhomocysteine (SAH), which is 
588 converted to homocysteine by S-adenosyl-L-homocysteine hydrolase (SAHH). 
589 Homocysteine can synthesize methionine by methionine synthase (MS) and vitamin B12 
590 or by betaine homocysteine methyltransferase (BHMT) and betaine. Homocysteine might 
591 also enter the TSP and be converted to cystathionine by cystathionine β-synthase (CBS), 
592 which can be processed to cysteine by the cystathionine γ-lyase (CGL), both reactions 
593 using vitamin B6 as a cofactor. Cysteine can be used to build proteins and in the 
594 synthesis of glutathione (GSH) and taurine.
595
596 Figure 2: H2S production. Hydrogen sulfide (H2S) is produced during the methionine 
597 metabolism from the catabolism of homocysteine and cysteine by the enzymatic activity 
598 of cystathionine β-synthase (CBS), cystathionine γ-lyase (CGL), and 3-mercaptopyruvate 
599 sulfurtransferase (MPST) alongside cysteine aminotransferase (CAT). The production of 
600 H2S might produce several cellular responses that cause stress resistance, vasodilation, 
601 antioxidant reactions, anti-inflammatory responses, and insulin release.
602
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Figure 1: Methionine cycle and transsulfuration pathway (TSP). Methionine is converted to 
S‐adenosylmethionine (SAM) by the methionine adenosyltransferase (MAT). Methyltransferases (MTs) 
produce S-adenosylhomocysteine (SAH), which is converted to homocysteine by S-adenosyl-L-homocysteine 
hydrolase (SAHH). Homocysteine can synthesize methionine by methionine synthase (MS) and vitamin B12 
or by betaine homocysteine methyltransferase (BHMT) and betaine. Homocysteine might also enter the TSP 
and be converted to cystathionine by cystathionine β-synthase (CBS), which can be processed to cysteine by 
the cystathionine γ-lyase (CGL), both reactions using vitamin B6 as a cofactor. Cysteine can be used to build 
proteins and in the synthesis of glutathione (GSH) and taurine. 
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Figure 2: H2S production. Hydrogen sulfide (H2S) is produced during the methionine metabolism from the 
catabolism of homocysteine and cysteine by the enzymatic activity of cystathionine β-synthase (CBS), 
cystathionine γ-lyase (CGL), and 3-mercaptopyruvate sulfurtransferase (MPST) alongside cysteine 
aminotransferase (CAT). The production of H2S might produce several cellular responses that cause stress 
resistance, vasodilation, antioxidant reactions, anti-inflammatory responses, and insulin release. 
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